Back to top
more

Soleno Therapeutics (SLNO)

(Delayed Data from NSDQ)

$38.52 USD

38.52
290,932

+1.38 (3.72%)

Updated Apr 15, 2024 04:00 PM ET

After-Market: $38.53 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (153 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for SLNO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

1 item in cart

View Cart/Checkout

Soleno Therapeutics, Inc. [SLNO]

Reports for Purchase

Showing records 1 - 20 ( 34 total )

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 1

11/22/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for SLNO 112223

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 2

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for SLNO

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 3

01/30/2020

Company Report

Pages: 4

Dropping Coverage

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 4

01/24/2020

Industry Report

Pages: 2

Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 5

01/22/2020

Industry Report

Pages: 8

Healthcare: Takeaways from our PWS Doc Call with Dr. Theresa Strong - Must Read

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 6

01/21/2020

Industry Report

Pages: 7

Healthcare - Join our PWS Call with Dr. Strong on Today at 12pm ET

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 7

01/20/2020

Industry Report

Pages: 4

2020 Is the Year of PWS: Bolster Your Know-How With Dr. Strong on Jan. 21

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 8

01/17/2020

Industry Report

Pages: 11

Healthcare -Join Our 1Q20 Doc Call Series in PWS, NASH, Omega-3s and Contraception

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 9

01/10/2020

Industry Report

Pages: 11

Healthcare Join Our 1Q20 Doc Call Series

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 10

08/08/2019

Company Report

Pages: 8

2Q19: Enrollment into PWS Trial Not Easy For Anyone - Read Our Analysis

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 11

08/08/2019

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 12

07/23/2019

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 13

07/23/2019

Company Report

Pages: 7

Join Our Call with Dr. Strong on July 31 to Predict DESTINY PWS Readout

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 14

05/24/2019

Industry Report

Pages: 3

Healthcare -Recap of Our 27 Most Valuable Industry Notes in 2019

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 15

05/15/2019

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 16

05/14/2019

Company Report

Pages: 6

1Q19 - Taking Off Full Steam in 3Q19

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 17

03/22/2019

Industry Report

Pages: 24

Healthcare - From NYC to Vienna - EASL Abstracts Galore: Attend our NASH Conference Mar. 28

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 75.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 18

03/15/2019

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 19

03/15/2019

Company Report

Pages: 6

Steady As It Goes Until DESTINY Readout

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Soleno Therapeutics, Inc.

Industry: Medical - Drugs

Record: 20

03/05/2019

Daily Note

Pages: 3

Reasons Why You Can''t Miss Our 2nd Battle of NASH Thrones Conference on Mar. 28

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party